These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12566027)

  • 1. Scleritis and other ocular side effects associated with pamidronate disodium.
    Fraunfelder FW; Fraunfelder FT; Jensvold B
    Am J Ophthalmol; 2003 Feb; 135(2):219-22. PubMed ID: 12566027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pamidronate disodium and possible ocular adverse drug reactions.
    Macarol V; Fraunfelder FT
    Am J Ophthalmol; 1994 Aug; 118(2):220-4. PubMed ID: 8053468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior uveitis: an under-recognized adverse effect of pamidronate: 2 case reports.
    Haverbeke G; Pertile G; Claes C; Zeyen T
    Bull Soc Belge Ophtalmol; 2003; (290):71-6. PubMed ID: 14750233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced ocular inflammatory diseases.
    Fraunfelder FW
    Drugs Today (Barc); 2007 Feb; 43(2):117-23. PubMed ID: 17353948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anterior uveitis and diffuse scleritis after pamidronate infusion.
    Xie JS; Kaplan AJ
    CMAJ; 2023 Dec; 195(49):E1722. PubMed ID: 38110218
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical characteristics of a large cohort of patients with scleritis and episcleritis.
    Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS
    Ophthalmology; 2012 Jan; 119(1):43-50. PubMed ID: 21963265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular Side Effects of Bisphosphonates: A Review of Literature.
    Chartrand NA; Lau CK; Parsons MT; Handlon JJ; Ronquillo YC; Hoopes PC; Moshirfar M
    J Ocul Pharmacol Ther; 2023; 39(1):3-16. PubMed ID: 36409537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paget's disease: ocular complications of disodium pamidronate treatment.
    O'Donnell NP; Rao GP; Aguis-Fernandez A
    Br J Clin Pract; 1995; 49(5):272-3. PubMed ID: 7492469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced ocular inflammation.
    Samalia P; Sims J; Niederer R
    N Z Med J; 2020 Dec; 133(1527):83-94. PubMed ID: 33332330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial.
    Patel DV; Bolland M; Nisa Z; Al-Abuwsi F; Singh M; Horne A; Reid IR; McGhee CN
    Osteoporos Int; 2015 Feb; 26(2):499-503. PubMed ID: 25187119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral severe fibrinous anterior uveitis--an unusual complication of pamidronate therapy exacerbated by topical latanoprost.
    Ramasamy B; Quah S; Sahni JN; Palimar P
    J Ocul Pharmacol Ther; 2007 Oct; 23(5):513-5. PubMed ID: 17900233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral Acute Anterior Uveitis and Conjunctivitis following Intravenous Zoledronic Acid.
    Chatterjee S; Agrawal D
    J Assoc Physicians India; 2017 Jul; 65(7):110-111. PubMed ID: 28792180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
    French DD; Margo CE
    Retina; 2008 Jun; 28(6):889-93. PubMed ID: 18536608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical case of the month. Bilateral optic neuropathy secondary to biphosphonate therapy].
    Lespagnard S; Bonnet S; Betz P
    Rev Med Liege; 2010; 65(7-8):434-6. PubMed ID: 20857699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate-associated scleritis: a case report and review.
    Leung S; Ashar BH; Miller RG
    South Med J; 2005 Jul; 98(7):733-5. PubMed ID: 16108245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the clinical manifestation of 90 cases with scleritis and episcleritis].
    Zhou Y; Wang Z; Zhang Y; Sun X
    Zhonghua Yan Ke Za Zhi; 2014 Apr; 50(4):261-6. PubMed ID: 24931151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute retinal pigment epithelial detachment secondary to pamidronate administration.
    Dasanu CA; Alexandrescu DT
    J Oncol Pharm Pract; 2009 Jun; 15(2):119-21. PubMed ID: 18818218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
    Wang L; Yang Y; Jia Y; Miao H; Zhou YS; Zhang XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1081-1085. PubMed ID: 27987518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study.
    Etminan M; Forooghian F; Maberley D
    CMAJ; 2012 May; 184(8):E431-4. PubMed ID: 22470169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular side effects associated with bisphosphonates.
    Fraunfelder FW
    Drugs Today (Barc); 2003 Nov; 39(11):829-35. PubMed ID: 14702129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.